Skip to main content
Premium Trial:

Request an Annual Quote

Dutch, Indian Companies to Form Nutrigenomics Joint Venture

NEW YORK, Nov. 23 (GenomeWeb News) - Avestha Gengraine Technologies and TNO Quality of Life said plan to form a joint venture as part of their plan to develop genomic-based and plant-derived nutritional products.

Avestha is based in Indiaand TNO is based in the Netherlands. Terms of the alliance call for the companies to combine "traditional" plant-based medicine developed in Indiawith genomic technologies to study metabolic syndrome, diabetes, obesity, and cardiovascular diseases, the companies said.

TNO has developed several human disease models in animals and have a model for kinetic studies in digestive physiology, as well as expertise in nutrigenomics research. Currently, the company is a coordinator of the European Union's Human Nutrigenomics Project.


For its part, Avesthagen will bring to the collaboration its experience in India's traditional medicine, access to bioactive plant extracts, and expertise in plant genetic technologies.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.